Study, Commentary Examine XDR-TB Treatment Outcomes In S. Africa

A post in the Center for Global Health Policy’s “Science Speaks” blog discusses a study and commentary published last week in The Lancet that evaluated the long-term outcomes of extensively drug-resistant tuberculosis (XDR-TB) patients in South Africa. “…Both the report and commentary call for policymakers and national control programs to urgently develop strategies to use existing public health instruments for TB control. They also argue for community-based interventions and the creation of palliative care facilities to minimize disease spread by patients who fail treatment” (Aziz, 4/7).